Guido Stoll Selected Research

Guido Stoll Research Topics

Disease

50	Stroke (Strokes) 06/2022 - 03/2006
26	Thrombosis (Thrombus) 10/2021 - 11/2005
24	Ischemic Stroke 03/2022 - 05/2007
23	Infarction (Infarctions) 05/2022 - 01/2002
19	Inflammation (Inflammations) 01/2022 - 01/2002
17	Brain Ischemia (Cerebral Ischemia) 01/2016 - 01/2002
15	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2022 - 01/2002
8	Hemorrhage 03/2022 - 03/2006
7	Neuroinflammatory Diseases 01/2022 - 01/2007
6	Reperfusion Injury 06/2022 - 05/2015
6	Cerebral Infarction 05/2022 - 11/2003
6	Brain Infarction 08/2021 - 04/2008
6	Wallerian Degeneration 03/2008 - 01/2002
5	Ischemia 11/2019 - 01/2002
4	Multiple Sclerosis 01/2019 - 09/2008
4	Peripheral Nerve Injuries 07/2012 - 11/2003
4	Edema (Dropsy) 04/2011 - 01/2009
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2010 - 01/2007
4	Demyelinating Diseases (Demyelinating Disease) 09/2008 - 10/2003
3	Brain Edema (Cerebral Edema) 04/2011 - 01/2009
2	Hypoxia (Hypoxemia) 06/2022 - 04/2011
2	Atrophy 01/2022 - 01/2018
2	Cognitive Dysfunction 01/2022 - 01/2018
2	Myasthenia Gravis 10/2019 - 07/2002
2	Cerebral Hemorrhage 01/2017 - 12/2015
2	Myocardial Infarction 07/2012 - 04/2010
2	Nerve Degeneration 06/2010 - 03/2005
2	Neuralgia (Stump Neuralgia) 03/2010 - 08/2006
2	Experimental Autoimmune Neuritis 03/2008 - 01/2006
1	Heart Failure 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Muscle Weakness 10/2019

Drug/Important Bio-Agent (IBA)

10	Contrast MediaIBA 01/2013 - 03/2005
9	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2004
9	Glycoproteins (Glycoprotein)IBA 02/2021 - 04/2009
9	CytokinesIBA 05/2019 - 01/2002
9	Factor XII (Hageman Factor)IBA 01/2019 - 03/2006
8	ferric oxide (iron oxide)IBA 01/2011 - 11/2003
7	von Willebrand FactorIBA 01/2014 - 04/2009
7	gadofluorine MIBA 11/2009 - 03/2005
6	GadoliniumIBA 01/2019 - 03/2005
5	AntigensIBA 02/2021 - 05/2010
5	KininsIBA 11/2012 - 01/2009
5	Messenger RNA (mRNA)IBA 01/2007 - 01/2002
4	ChemokinesIBA 01/2022 - 08/2006
4	CalciumIBA 11/2019 - 07/2008
4	LigandsIBA 01/2019 - 04/2009
4	Bradykinin Receptors (Bradykinin Receptor)IBA 03/2011 - 05/2008
3	EnzymesIBA 06/2022 - 06/2010
3	InflammasomesIBA 03/2022 - 01/2021
3	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2022 - 10/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2011
3	Platelet Membrane GlycoproteinsIBA 01/2022 - 12/2015
3	Immunoglobulin G (IgG)IBA 03/2021 - 03/2015
3	AntibodiesIBA 10/2019 - 06/2013
3	Collagen ReceptorsIBA 01/2016 - 10/2010
3	triphenyltetrazoliumIBA 12/2015 - 05/2007
3	IronIBA 06/2010 - 06/2005
3	Interleukin-18 (Interleukin 18)IBA 01/2010 - 01/2002
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2009 - 01/2002
3	Interleukin-1beta (Interleukin 1 beta)IBA 01/2006 - 01/2002
2	HMGB1 Protein (HMG1)IBA 10/2021 - 08/2021
2	adhesion receptorIBA 02/2021 - 04/2009
2	Caspase 1 (ICE Protease)IBA 01/2021 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 04/2011
2	Oxygen (Dioxygen)IBA 11/2019 - 01/2009
2	Pharmaceutical PreparationsIBA 11/2019 - 09/2010
2	CollagenIBA 04/2019 - 10/2010
2	Factor XIIa (Coagulation Factor XIIa)IBA 01/2016 - 01/2016
2	LipidsIBA 09/2013 - 07/2006
2	CoagulantsIBA 07/2013 - 09/2011
2	FluorocarbonsIBA 07/2012 - 01/2011
2	von Willebrand factor receptor (VWF receptor)IBA 09/2011 - 10/2010
2	Immunoglobulin Fab FragmentsIBA 04/2011 - 05/2007
2	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 04/2011 - 05/2007
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 06/2010 - 06/2005
2	FibrinIBA 04/2010 - 03/2006
2	Myelin-Oligodendrocyte GlycoproteinIBA 02/2010 - 09/2008
2	Interleukin-1 (Interleukin 1)IBA 01/2010 - 01/2002
2	Gadolinium DTPA (Magnevist)FDA Link 11/2009 - 03/2008
2	Peptide Hydrolases (Proteases)FDA Link 04/2008 - 03/2006
2	Coloring Agents (Dyes)IBA 04/2008 - 05/2002
2	Rose BengalIBA 04/2008 - 05/2002
2	Monoclonal AntibodiesIBA 05/2007 - 01/2006
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2007 - 01/2004
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2006 - 01/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006 - 01/2002
1	EndoglinIBA 06/2022
1	ImmunosorbentsIBA 06/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	platelet membrane glycoprotein VIIBA 10/2021
1	AlbuminsIBA 03/2021
1	Therapeutic UsesIBA 02/2021
1	Calcium Channels (Calcium Channel)IBA 11/2019
1	Cholinergic ReceptorsIBA 10/2019
1	Cholinergic Agents (Cholinergics)IBA 10/2019

Therapy/Procedure

12	Thrombectomy 05/2022 - 10/2018
6	Therapeutics 10/2021 - 06/2010
2	Microelectrodes 08/2019 - 05/2019